| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 6, 832-839, Copyright © 1992 by The Federation of American Societies for Experimental Biology
REVIEWS |
DB Bylund
Department of Pharmacology, College of Medicine, University of Nebraska Medical Center, Omaha 68198-6260.
The adrenergic receptors are members of the superfamily of G protein- coupled receptors. There are three major types of adrenergic receptors: alpha 1, alpha 2, and beta. Each of these three major types can be divided into three subtypes. Within the alpha 1-adrenergic receptors, alpha 1A and alpha 1B subtypes have been defined pharmacologically on the basis of reversible antagonists, such as WB4101 and phentolamine, and the irreversible antagonist chloroethylclonidine. In at least some tissues the mechanism of action of the alpha 1A subtype is related to activation of a calcium channel, whereas the alpha 1B receptor exerts its effect through the second messenger inositol trisphosphate. Both of these receptor subtypes as well as a third, the alpha 1C, have been identified by molecular cloning. Three pharmacological subtypes of the alpha 2-adrenergic receptor have also been identified. Prototypic tissues and cell lines in continuous culture have been developed for each of these subtypes, which facilitated their study. The definition of the alpha 2 subtypes has been based on radioligand binding data and more limited functional data. All three subtypes have been shown to inhibit the activation of adenylate cyclase and thus reduce the levels of cAMP. Three alpha 2-adrenergic receptor subtypes have been identified by molecular cloning in both the human and rat species. There is reasonable agreement between the pharmacological identified subtypes and those identified by molecular cloning.
This article has been cited by other articles:
|
|
 |
|
  R. Gilsbach, M. Brede, N. Beetz, E. Moura, V. Muthig, C. Gerstner, F. Barreto, S. Neubauer, M. A. Vieira-Coelho, and L. Hein Heterozygous {alpha}2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction Cardiovasc Res, September 1, 2007; 75(4): 728 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. B. Fenik, R. O. Davies, and L. Kubin REM Sleep-like Atonia of Hypoglossal (XII) Motoneurons Is Caused by Loss of Noradrenergic and Serotonergic Inputs Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1322 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J Haug and S. S Segal Sympathetic neural inhibition of conducted vasodilatation along hamster feed arteries: complementary effects of {alpha}1- and {alpha}2-adrenoreceptor activation J. Physiol., March 1, 2005; 563(2): 541 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Plut, C. Ribiere, Y. Giudicelli, and J.-P. Dausse Gender Differences in Hypothalamic Tyrosine Hydroxylase and alpha 2-Adrenoceptor Subtype Gene Expression in Cafeteria Diet-Induced Hypertension and Consequences of Neonatal Androgenization J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 525 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Bishai, L. Penninga, R. Nijland, R. Meulenaar, C. P. Gheorghe, Y. Zhao, J. N. Buchholz, L. Zhang, and L. D. Longo Pre- and postjunctional alpha 2-adrenergic receptors in fetal and adult ovine cerebral arteries Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1654 - R1662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kintsurashvili, I. Gavras, C. Johns, and H. Gavras Effects of Antisense Oligodeoxynucleotide Targeting of the {alpha}2B-Adrenergic Receptor Messenger RNA in the Central Nervous System Hypertension, November 1, 2001; 38(5): 1075 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Rekling, G. D. Funk, D. A. Bayliss, X.-W. Dong, and J. L. Feldman Synaptic Control of Motoneuronal Excitability Physiol Rev, April 1, 2000; 80(2): 767 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Michel, C. Plogmann, T. Philipp, and O.-E. Brodde Functional correlates of {alpha}2A-adrenoceptor gene polymorphism in the HANE study Nephrol. Dial. Transplant., November 1, 1999; 14(11): 2657 - 2663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Bylund and D. M. Chacko Characterization of {alpha}2 Adrenergic Receptor Subtypes in Human Ocular Tissue Homogenates Invest. Ophthalmol. Vis. Sci., September 1, 1999; 40(10): 2299 - 2306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-D. Nguyen, P. Vequaud, and E. Thorin Effects of endothelin receptor antagonists and nitric oxide on myogenic tone and {alpha}-adrenergic-dependent contractions of rabbit resistance arteries Cardiovasc Res, August 15, 1999; 43(3): 755 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. DeGraff, A. W. Gagnon, J. L. Benovic, and M. J. Orsini Role of Arrestins in Endocytosis and Signaling of alpha 2-Adrenergic Receptor Subtypes J. Biol. Chem., April 16, 1999; 274(16): 11253 - 11259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Davies, T. T. T. Huynh, G. J. Fulton, R. J. Lefkowitz, E. Svendsen, P.-O. Hagen, and W. J. Koch G Protein Signaling and Vein Graft Intimal Hyperplasia : Reduction of Intimal Hyperplasia in Vein Grafts by a Gß{gamma} Inhibitor Suggests a Major Role of G Protein Signaling in Lesion Development Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1275 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Pfeiffer-Linn and E. M. Lasater Multiple Second-Messenger System Modulation of Voltage-Activated Calcium Currents in Teleost Retinal Horizontal Cells J Neurophysiol, July 1, 1998; 80(1): 377 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Thorin, P. L. Huang, M. C. Fishman, and J. A. Bevan Nitric Oxide Inhibits {alpha}2-Adrenoceptor–Mediated Endothelium-Dependent Vasodilation Circ. Res., June 29, 1998; 82(12): 1323 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Porter, S. E. Edelmann, D. J. Waugh, M. T. Piascik, and D. M. Perez The Agonism and Synergistic Potentiation of Weak Partial Agonists by Triethylamine in alpha 1-Adrenergic Receptor Activation: Evidence for a Salt Bridge as the Initiating Process Mol. Pharmacol., April 1, 1998; 53(4): 766 - 771. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Zuscik, J. E. Porter, R. Gaivin, and D. M. Perez Identification of a Conserved Switch Residue Responsible for Selective Constitutive Activation of the beta 2-Adrenergic Receptor J. Biol. Chem., February 6, 1998; 273(6): 3401 - 3407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ruan, H. Kan, J.-H. Parmentier, S. Fatima, L. F. Allen, and K. U. Malik Alpha-1A Adrenergic Receptor Stimulation with Phenylephrine Promotes Arachidonic Acid Release by Activation of Phospholipase D in Rat-1 Fibroblasts: Inhibition by Protein Kinase A J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 576 - 585. [Abstract] [Full Text]
|
|
|
|
|
|
R.-X. Wang and L. E. Limbird Distribution of mRNA Encoding Three alpha 2-Adrenergic Receptor Subtypes in the Developing Mouse Embryo Suggests a Role for the alpha 2A Subtype in Apoptosis Mol. Pharmacol., December 1, 1997; 52(6): 1071 - 1080. [Abstract] [Full Text]
|
|
|
|
|
|
E. Thorin, S. M. Shreeve, N. Thorin-Trescases, and J. A. Bevan Reversal of Endothelin-1 Release by Stimulation of Endothelial {alpha}2-Adrenoceptor Contributes to Cerebral Vasorelaxation Hypertension, October 1, 1997; 30(4): 830 - 836. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. T. Schmeling and N. E. Farber The Effects of {alpha}2-Adrenergic Agonists on the Cardiovascular System Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1997; 1(2): 178 - 196. [PDF]
|
|
|
|
|
|
D. B. Bylund, L. J. Iversen, W. J. Matulka, and D. M. Chacko J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1171 - 1177. [Abstract] [Full Text]
|
|
|
|
|
|
J. E. Porter, J. Hwa, and D. M. Perez Activation of the alpha 1b-Adrenergic Receptor Is Initiated by Disruption of an Interhelical Salt Bridge Constraint J. Biol. Chem., November 8, 1996; 271(45): 28318 - 28323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wen, T. Cheng, Y. Li, W. Cao, and R. H. Steinberg alpha 2-Adrenergic Agonists Induce Basic Fibroblast Growth Factor Expression in Photoreceptors In Vivo and Ameliorate Light Damage J. Neurosci., October 1, 1996; 16(19): 5986 - 5992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. deBlois, S.M. Schwartz, E.M. van Kleef, J.E. Su, K.A. Griffin, A.K. Bidani, M.J.A.P. Daemen, and D.M. Lombardi Chronic {alpha}1-Adrenoreceptor Stimulation Increases DNA Synthesis in Rat Arterial Wall: Modulation of Responsiveness After Vascular Injury Arterioscler. Thromb. Vasc. Biol., September 1, 1996; 16(9): 1122 - 1129. [Abstract] [Full Text]
|
|
|
|
|
|
D. E. Handy and H. Gavras Evidence for Cell-Specific Regulation of Transcription of the Rat {alpha}2A-Adrenergic Receptor Gene Hypertension, April 1, 1996; 27(4): 1018 - 1024. [Abstract] [Full Text]
|
|
|
|
|
|
A. Tavares, D. E. Handy, N. N. Bogdanova, D. L. Rosene, and H. Gavras Localization of {alpha}2A- and {alpha}2B-Adrenergic Receptor Subtypes in Brain Hypertension, March 1, 1996; 27(3): 449 - 455. [Abstract] [Full Text]
|
|
|
|
|
|
G. Gong, M. L. Johnson, and W. A. Pettinger Testosterone Regulation of Renal {alpha}2B-Adrenergic Receptor mRNA Levels Hypertension, March 1, 1995; 25(3): 350 - 355. [Abstract] [Full Text]
|
|
|
|
|
|
C. S. Flordellis, M. Berguerand, P. Gouache, Vér. Barbu, H. Gavras, D. E. Handy, G. Béréziat, and J.ël. Masliah alpha(2)Adrenergic Receptor Subtypes Expressed in Chinese Hamster Ovary Cells Activate Differentially Mitogen-activated Protein Kinase by a p21[IMAGE] Independent Pathway J. Biol. Chem., February 24, 1995; 270(8): 3491 - 3494. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
